Literature DB >> 19269005

Peripheral squamous cell carcinoma of lung: patterns of growth with particular focus on airspace filling.

Samuel A Yousem1.   

Abstract

Because the clinical behavior of low-stage adenocarcinomas of the lung is best predicted when adjusted for the presence of a lepidic growth pattern, we studied the marginal growth patterns of 62 peripheral squamous cell carcinomas of lung focusing on the patterns of marginal/peripheral growth and presence of an alveolar filling component. Approximately one fourth of squamous carcinomas had 20% of their gross diameters composed of carcinoma cells filling airspaces with preserved alveolar architecture, and 26% of these cases had their gross size downgraded from a T2 to a T1 lesion. Despite this size recalculation, insufficient numbers of cases made it impossible to determine if this change had independent prognostic significance for T1/T2N0 lesions. Nonetheless, such a growth pattern was common and should be studied further in larger series to determine if an airspace filling growth pattern in squamous carcinoma is clinically important.

Entities:  

Mesh:

Year:  2009        PMID: 19269005     DOI: 10.1016/j.humpath.2008.11.008

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  14 in total

1.  Interstitial growth as an aggressive growth pattern in primary lung cancer.

Authors:  Shigeki Suzuki; Keiju Aokage; Tomoyuki Hishida; Junji Yoshida; Takeshi Kuwata; Chisako Yamauchi; Masahiro Tsuboi; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-25       Impact factor: 4.553

Review 2.  Vessel co-option in cancer.

Authors:  Elizabeth A Kuczynski; Peter B Vermeulen; Francesco Pezzella; Robert S Kerbel; Andrew R Reynolds
Journal:  Nat Rev Clin Oncol       Date:  2019-08       Impact factor: 66.675

Review 3.  Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?

Authors:  Tom Donnem; Jiangting Hu; Mary Ferguson; Omanma Adighibe; Cameron Snell; Adrian L Harris; Kevin C Gatter; Francesco Pezzella
Journal:  Cancer Med       Date:  2013-07-08       Impact factor: 4.452

Review 4.  Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions.

Authors:  Naveen S Vasudev; Andrew R Reynolds
Journal:  Angiogenesis       Date:  2014-01-31       Impact factor: 9.596

5.  SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin.

Authors:  Giustina Ferone; Ji-Ying Song; Kate D Sutherland; Rajith Bhaskaran; Kim Monkhorst; Jan-Paul Lambooij; Natalie Proost; Gaetano Gargiulo; Anton Berns
Journal:  Cancer Cell       Date:  2016-10-10       Impact factor: 31.743

6.  The changing anatomic position of squamous cell carcinoma of the lung - a new conundrum.

Authors:  William Krimsky; Nargiz Muganlinskaya; Saiyad Sarkar; Manasa Vulchi; Pujan Patel; Suman Rao; Joel Hammer; Ruth Evans; Muhammad Qureshi; Daniel Harley
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-12-15

7.  Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.

Authors:  Victoria L Bridgeman; Peter B Vermeulen; Shane Foo; Agnes Bilecz; Frances Daley; Eleftherios Kostaras; Mark R Nathan; Elaine Wan; Sophia Frentzas; Thomas Schweiger; Balazs Hegedus; Konrad Hoetzenecker; Ferenc Renyi-Vamos; Elizabeth A Kuczynski; Naveen S Vasudev; James Larkin; Martin Gore; Harold F Dvorak; Sandor Paku; Robert S Kerbel; Balazs Dome; Andrew R Reynolds
Journal:  J Pathol       Date:  2016-12-29       Impact factor: 7.996

8.  Role of (myo)fibroblasts in the development of vascular and connective tissue structure of the C38 colorectal cancer in mice.

Authors:  Edina Bugyik; Vanessza Szabó; Katalin Dezső; András Rókusz; Armanda Szücs; Péter Nagy; József Tóvári; Viktória László; Balázs Döme; Sándor Paku
Journal:  Cancer Commun (Lond)       Date:  2018-07-05

9.  Difference of morphology and immunophenotype between central and peripheral squamous cell carcinomas of the lung.

Authors:  Tomayoshi Hayashi; Hisao Sano; Ryoko Egashira; Kazuhiro Tabata; Tomonori Tanaka; Toshiyuki Nakayama; Yukio Kashima; Takashi Hori; Sayuri Nunomura; Junya Fukuoka
Journal:  Biomed Res Int       Date:  2013-08-29       Impact factor: 3.411

Review 10.  Prognostic factors in resected lung carcinomas.

Authors:  Keith M Kerr; Marianne C Nicolson
Journal:  EJC Suppl       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.